CBS and malignant colon neoplasm: In order to identify the rpL3 molecular targets that mediate its pro-apoptotic function upon drug-induced nucleolar stress [8–10], we became interested to assess the intracellular levels of CBS after 5-FU treatment in human colon cancer cells devoid of p53.